Shares of biotech Moderna (NASDAQ: MRNA), maker of a COVID-19 vaccine, dropped 31.6% in December, according to data from S&P Global Market Intelligence.
For context, the S&P 500 returned 3.8% last month.
Image source: Getty Images.
Why Moderna Stock Fell 32% in December
Latest from Blog
Marijuana stocks have been on fire lately. Many investors are hoping that a Democratic-controlled senate will…
If investors entered 2020 unsure of their convictions, they know them now. The unprecedented uncertainty created…
Are you looking for a great dividend stock to add to your portfolio? There are many…
When you consider Wells Fargo‘s (NYSE: WFC) fake accounts scandal, where more than 3 million accounts…
DocuSign (NASDAQ: DOCU) has certainly grown impressively, and investors have been handsomely rewarded. Since its 2018…